凝血分析儀市場規模、佔有率和成長分析（按產品、測試、技術、最終用戶和地區）- 產業預測 2025-2032

2023 年全球凝血分析儀市場規模價值 42 億美元，預計將從 2024 年的 44.4 億美元成長到 2032 年的 69.8 億美元，預測期內（2025-2032 年）的複合年成長率為 5.8%。

受血液凝固障礙和心血管疾病發病率上升的推動，全球凝血分析儀市場正在經歷強勁成長。這些分析儀在抗凝血治療的有效監測和管理中發揮關鍵作用。推動市場擴張的關鍵因素包括技術進步以實現更快、更準確的結果以及醫療保健支出的增加。此外，隨著領先公司推出旨在改善患者治療效果的創新解決方案，對攜帶式和易於使用的設備的需求也日益增加。然而，挑戰依然存在，包括定價壓力和嚴格的法律規範。雖然北美和歐洲繼續佔據市場佔有率的首位，但亞太地區已成為一個有希望的成長地區。整體而言，由於對高效凝血監測解決方案的需求不斷成長，市場前景依然樂觀。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管分析

凝血分析儀市場規模（依產品及複合年成長率） (2025-2032)

• 市場概況
• 臨床檢測與分析設備
  • 耗材
  • 試劑
  • 標準控制校準
  • 系統
  • 自動化系統
  • 半自動系統
  • 手動系統
• 就地檢驗和分析設備

凝血分析儀市場規模（依測試類型和複合年成長率） （2025-2032）

• 市場概況
• 凝血酶原時間檢測
• D-二聚體檢測
• 纖維蛋白原檢測
• 活化凝血時間檢測
• 活化部份凝血活酵素時間試驗
• 血小板功能檢查
• 抗XA因子檢測
• ACT 的肝素和魚精蛋白劑量反應測試
• 其他血液凝固檢驗

凝血分析儀市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• 光學技術
• 機械工業
• 電化學技術
• 其他技術

凝血分析儀市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 臨床實驗室
• 其他最終用戶

凝血分析儀市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Abbott Laboratories（United States）
• Sysmex Corporation（Japan）
• Thermo Fisher Scientific（United States）
• Instrumentation Laboratory（IL）（United States）
• Helena Laboratories（United States）
• Nihon Kohden（Japan）
• Diagnostica Stago（France）
• Werfen（Spain）
• Grifols（Spain）
• International Technidyne Corporation（ITC）（United States）
• HemoSonics（United States）
• Randox Laboratories（United Kingdom）
• Helena Point of Care（United States）
• Medtronic（Ireland）
• EKF Diagnostics（United Kingdom）

結論和建議

Global Coagulation Analyzer Market size was valued at USD 4.2 billion in 2023 and is poised to grow from USD 4.44 billion in 2024 to USD 6.98 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The global coagulation analyzer market is experiencing robust growth, propelled by the increasing prevalence of clotting disorders and cardiovascular diseases. These analyzers play a vital role in the effective monitoring and management of anticoagulant therapies. Key factors fueling market expansion include technological advancements that facilitate faster, more precise results and rising healthcare expenditures. The demand for portable, user-friendly devices is also on the rise, as major players introduce innovative solutions aimed at improving patient outcomes. However, challenges such as pricing pressures and stringent regulatory frameworks persist. While North America and Europe continue to lead in market share, the Asia-Pacific region is emerging as a promising growth area. Overall, the market outlook remains positive, driven by the escalating need for efficient coagulation monitoring solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coagulation Analyzer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coagulation Analyzer Market Segments Analysis

Global Coagulation Analyzer Market is segmented by Product, Test, Technology, End User and region. Based on Product, the market is segmented into Clinical Laboratory Analyzers and Point-Of-Care Testing Analyzers. Based on Test, the market is segmented into Prothrombin Time Testing, D-Dimer Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, Platelet Function Tests, Anti-Factor XA Tests, Heparin & Protamine Dose Response Tests for Act and Other Coagulation Tests. Based on Technology, the market is segmented into Optical Technology, Mechanical Technology, Electrochemical Technology and Other Technologies. Based on End User, the market is segmented into Hospitals, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Coagulation Analyzer Market

The aging global population is contributing to a heightened prevalence of several medical conditions, particularly coagulation disorders. As the number of elderly individuals rises, there will be a corresponding surge in the need for coagulation analyzers that facilitate the diagnosis and management of clotting issues like deep vein thrombosis (DVT) and hemophilia. This increased demand is driven by the urgent requirement for efficient monitoring and treatment solutions to address these disorders effectively, which positions the global coagulation analyzer market for significant growth in response to the healthcare needs of an aging demographic.

Restraints in the Global Coagulation Analyzer Market

The Global Coagulation Analyzer market faces significant restraints due to the high costs associated with purchasing and maintaining these devices. Smaller healthcare facilities and those in resource-limited areas often struggle with the substantial initial investment required along with ongoing expenses for maintenance, reagents, and regular calibration. These financial challenges can create barriers to acquiring advanced coagulation analyzers, limiting access to essential diagnostic tools and potentially impacting the quality of patient care in these regions. As a result, the economic constraints hinder the widespread adoption and utilization of coagulation analyzers worldwide.

Market Trends of the Global Coagulation Analyzer Market

The Global Coagulation Analyzer market is experiencing a significant shift due to technological advancements and increased automation, which are revolutionizing laboratory practices. Manufacturers are prioritizing the development of analyzers characterized by superior accuracy, efficiency, and intuitive user interfaces. Innovations such as barcode scanning, automated sample loading, and seamless integration with laboratory information systems are gaining traction, ultimately streamlining testing processes and mitigating human errors. This trend not only enhances laboratory productivity but also aligns with the growing demand for rapid and reliable diagnostic solutions in healthcare settings. As a result, the market is poised for robust growth as facilities adopt these advanced technologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Analysis

Global Coagulation Analyzer Market Size by Product & CAGR (2025-2032)

• Market Overview
• Clinical Laboratory Analyzers
  • Consumables
  • Reagents
  • Standards, Controls, and Calibrations
  • Systems
  • Automated systems
  • Semi-automated systems
  • Manual systems
• Point-Of-Care Testing Analyzers

Global Coagulation Analyzer Market Size by Test & CAGR (2025-2032)

• Market Overview
• Prothrombin Time Testing
• D-Dimer Testing
• Fibrinogen Testing
• Activated Clotting Time Testing
• Activated Partial Thromboplastin Time Testing
• Platelet Function Tests
• Anti-Factor XA Tests
• Heparin & Protamine Dose Response Tests for Act
• Other Coagulation Tests

Global Coagulation Analyzer Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Optical Technology
• Mechanical Technology
• Electrochemical Technology
• Other Technologies

Global Coagulation Analyzer Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinical Laboratories
• Other End Users

Global Coagulation Analyzer Market Size & CAGR (2025-2032)

• North America (Product, Test, Technology, End User)
  • US
  • Canada
• Europe (Product, Test, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Test, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Test, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (IL) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostica Stago (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Technidyne Corporation (ITC) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HemoSonics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Point of Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations